- Volume is elevated versus the 13-week average, confirming attention.
ISRG
NASDAQ
Week ended 24 Jul 2026
Weekly Investor Report
Intuitive Surgical Inc · Healthcare · Medical Instruments & Supplies
Latest close
337.5 USD
-2.3%
latest week
Weekly setup
Weak trend
The weekly trend is not active. Price is -26.6% below the Trend Line and sits at 3.2% of its 52-week range. The latest completed week returned -2.3%, after a -16.6% four-week move. The latest factor snapshot indicates quality ranks strongly versus its universe; growth ranks strongly; valuation is expensive relative to peers. Options positioning is bullish with 36/100 conviction, while the latest news-sentiment score is 57/100. Near-term considerations: earnings are due in 82d.
Setup score
21
out of 100
Latest Close
337.5 USD
24 Jul 2026
1W Return
-2.3%
latest completed week
4W Return
-16.6%
short-term follow-through
12W Return
-26.3%
quarterly tape
Trend Breadth
17.3%
9 of 52 weeks active
Volume Ratio
1.7x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Activity pressure is negative, which weakens the current setup.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
-2.3%
Latest completed week; four-week move -16.6%.
Indicator stack
10/38
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Negative 41.17%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
Options pressure
Bullish
36/100 conviction; expected move 7.5%.
News sentiment
57/100
42 relevant articles in the latest sentiment read.
Event risk
82d
Next report is scheduled for 20 Oct 2026; event risk rises as the date approaches.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is -26.6% below the Trend Line and sits at 3.2% of its 52-week range. The latest completed week returned -2.3%, after a -16.6% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 1.7x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
30 Jan
6 Feb
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.0112-week average 0.01
12-week confirmation
Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure0/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.01Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is -16.6% over four weeks, -26.3% over 12 weeks, and -31.9% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year9
Trend breadth17.3%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure-0.67Latest activity-pressure read.
Pressure change1.4%Four-week change in activity pressure.
Leadership-35.83Latest relative-leadership reading.
RS change-26.6%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
The latest factor snapshot indicates quality ranks strongly versus its universe; growth ranks strongly; valuation is expensive relative to peers.
Factor week 26 Jul 2026
Financial statements through 31 Dec 2025
Field coverage 97%
Model confidence 97%
Relative factor standing
Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.
Overall factor strength11/100Blend of value, momentum, and quality. Underlying universe rank 90; rank 1 is best.
Value5/100Relative valuation strength. Underlying universe rank 96; rank 1 is best.
Quality94/100Profitability and accounting quality. Underlying universe rank 7; rank 1 is best.
Momentum12/100Medium-term price momentum. Underlying universe rank 89; rank 1 is best.
Growth93/100Revenue and earnings growth. Underlying universe rank 8; rank 1 is best.
Quality and valuation are separate questions
A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.
Value-quality framework31/100Value and quality alignment from the Sharemaestro SVQF framework.
Valuation
How much investors are paying for earnings, sales, and cash flow.
- P/E
- 38.5x Price divided by trailing earnings.
- Price / sales
- 11.0x Market value relative to trailing revenue.
- EV / EBITDA
- 26.3x Enterprise value relative to operating cash earnings.
- Free-cash-flow yield
- 3.5% Free cash flow as a share of enterprise value.
Business quality
Margins and the return generated on invested capital.
- Gross margin
- 66.7% Gross profit retained from each unit of revenue.
- Operating margin
- 33.8% Operating profit retained from revenue.
- Free-cash-flow margin
- 38.0% Free cash flow generated from revenue.
- Return on invested capital
- 19.7% Operating return generated on invested capital.
Growth and financial strength
Recent business growth and accounting strength.
- Revenue growth
- 20.7% Latest one-year revenue growth.
- EPS growth
- 20.4% Latest one-year earnings-per-share growth.
- Free-cash-flow growth
- 14.6% Latest one-year free-cash-flow growth.
- Piotroski F-score
- 6/9 Nine-point accounting-strength checklist.
Shareholder return and balance sheet
Cash returned to owners and financial leverage.
- Dividend yield
- - Cash dividends relative to market value.
- Buyback yield
- 2.6% Net share repurchases relative to market value.
- Shareholder yield
- 2.6% Dividend yield plus net buyback yield.
- Net debt / EBITDA
- -0.5x Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Options positioningBullish
ISRG shows bullish options pressure with a 36/100 conviction score, put-call volume ratio of 0.63, expected move of 7.5%, and Sharemaestro trend signal inactive.
Conviction36/100
Expected move7.5%
Put/call volume0.63
Insider activity3 / 17
3 acquisitions and 17 disposals in the latest 180-day insider tape.
Acquisitions / disposals over the latest 180 days. Insider activity is context, not a stand-alone signal.News sentiment57/100
Weighted news tone is neutral across 42 relevant articles.
17 positive · 22 neutral · 3 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings82dNext report is scheduled for 20 Oct 2026; event risk rises as the date approaches.
Options expected move7.5%Nearest-chain priced movement where available.
52-week drawdown-44.1%Distance below the 52-week high.
13-week volatility4.8%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
30 Jan
27 Feb
27 Mar
24 Apr
22 May
19 Jun
24 Jul
Weeks higher6 of 2620 weeks finished lower.
Best week+5.3%Week of 3 Jul.
Worst week-15.1%Week of 17 Jul.
Latest week-2.3%Week of 24 Jul.
Shape of recent returns
Strong gains3
Modest gains3
Flat weeks0
Modest losses15
Sharp losses5
Recent vol4.8%13-week weekly-return volatility.
Base vol5.0%52-week weekly-return volatility.
Up/down split18/34Count of positive and negative weeks in the 52-week window.
Average skew4.1% / -3.1%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorUS Healthcare
4-week rank97 / 100
Group average1.3%
Trend breadth51.0%
Trend51.0%active weekly trend signals
MD75.0%positive activity pressure
RS48.0%positive relative leadership
Four-week leaders
IndustryUS Medical Instruments & Supplies
4-week rank44 / 50
Group average-4.0%
Trend breadth38.0%
Trend38.0%active weekly trend signals
MD76.0%positive activity pressure
RS22.0%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape22/100
Trend, activity pressure, participation, and risk combine to a 22/100 tape read.
Indicator analysis9/100Latest 12-week confirmation: trend 0/12, activity pressure 0/12, relative leadership 0/12.
Activity pressure 0.01; No reversal markers Next-Week ExpectancyNegative 41.17%Next-week expectancy is negative with a 41.17% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors30/100O'Shaughnessy factor stack blends value, quality, momentum, and confidence.
Buyback Yield rank 20 SVQF31/100Value and quality alignment from the Sharemaestro SVQF framework.
Composite rank 501.5 of 726 Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Options49/100ISRG shows bullish options pressure with a 36/100 conviction score, put-call volume ratio of 0.63, expected move of 7.5%, and Sharemaestro trend signal inactive.
Bullish · Call-side pressure · Expected move 7.5% Sentiment57/100Weighted news tone is neutral across 42 relevant articles.
Is It Too Late to Buy Intuitive Surgical Inc (ISRG) After 5.7% R Insiders3 / 173 acquisitions and 17 disposals in the latest 180-day insider tape.
Earnings82dNext report is scheduled for 20 Oct 2026; event risk rises as the date approaches.
Research flow2 items0 recent research articles and 2 Market Watch posts are available.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 24 Jul 2026 | 337.5 USD | -2.3% | 459.7 USD | 452.2 USD | -0.67 | -35.83 | 23.8M | Off |
| 17 Jul 2026 | 345.4 USD | -15.1% | 467.7 USD | 452.1 USD | -0.54 | -35.99 | 28.9M | Off |
| 10 Jul 2026 | 406.8 USD | -4.5% | 475.3 USD | 452.0 USD | -0.54 | -28.52 | 11.3M | Off |
| 3 Jul 2026 | 426.0 USD | 5.3% | 479.8 USD | 451.7 USD | -0.63 | -24.47 | 10.0M | Off |
| 26 Jun 2026 | 404.7 USD | -0.5% | 484.8 USD | 451.1 USD | -0.68 | -28.30 | 14.1M | Off |
| 19 Jun 2026 | 406.8 USD | -1.0% | 490.4 USD | 450.7 USD | -0.78 | -31.83 | 11.1M | Off |
| 12 Jun 2026 | 411.1 USD | -2.6% | 495.6 USD | 450.2 USD | -0.76 | -29.98 | 10.2M | Off |
| 5 Jun 2026 | 422.1 USD | -0.6% | 500.2 USD | 449.7 USD | -0.69 | -27.14 | 14.8M | Off |
| 29 May 2026 | 424.6 USD | -3.1% | 504.8 USD | 449.0 USD | -0.75 | -30.74 | 10.4M | Off |
| 22 May 2026 | 438.1 USD | 4.0% | 508.5 USD | 448.2 USD | -0.73 | -27.31 | 10.7M | Off |
| 15 May 2026 | 421.1 USD | -6.4% | 512.1 USD | 447.4 USD | -0.56 | -30.00 | 12.9M | Off |
| 8 May 2026 | 450.1 USD | -1.7% | 512.9 USD | 446.7 USD | -0.64 | -26.25 | 10.7M | Off |
| 1 May 2026 | 457.8 USD | -5.1% | 512.2 USD | 445.8 USD | -0.77 | -21.69 | 9.4M | Off |
| 24 Apr 2026 | 482.2 USD | 2.8% | 512.0 USD | 444.8 USD | -0.87 | -16.98 | 15.8M | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.